US Drug Shortage Hits Patients, Pharmacies the Hardest
Patrick Stone, President, TradeStoneQA The corner drug store is not currently [...]
17
08, 2015
15
07, 2015
Will New User Fees Fuel More FDA Inspections?
For FY 2016, FDA is requesting $4.9 billion to support our essential functions a [...]
28
05, 2015
Big Pharma Goes Big for Big Data
When it comes to data, big pharma knows what big pharma likes, according to a ne [...]
11
05, 2015
Should FDA Get Tougher on IRBs?
Patrick Stone, President, TradeStoneQA The FDA says IRBs (Investigational Revi [...]
23
04, 2015
FDA’s Action Plan Demands Some Industry Action, Too
“The following Pharmaceuticals FY 2015 Action Plan (the Action Plan), developed [...]
9
04, 2015
FDA Plays Catch Up In Brave New World of Electronic Consent
Michael Causey, Editor & Publisher, eDataIntegrityReport.com Informed cons [...]
4
02, 2015
Training Management Best Practices for Emerging Life Science Companies
Jeff Mazik, Vice President, Life Science Solutions, AssurX No matter how good [...]
21
01, 2015
Quality Takes Time, FDA’s CDER Reminds Drug Makers
Michael Causey, Editor & Publisher, eDataIntegrityReport.com Scholars stil [...]
8
01, 2015
FDA’s CDER Unveils Ambitious 2015 Wish List
The holidays came a little early for the folks at the Center for Drug Evaluation [...]
30
12, 2014
FDA FastStats: A Look Back at all FDA 483 Inspectional Observations for Fiscal Year 2014
FDA FastStats: A Look Back at all FDA 483 Inspectional Observations for the Fisc [...]
